Reconciling ACEA and MCDA: is there a way forward for measuring cost-effectiveness in the U.S. healthcare setting?

BACKGROUND: The ISPOR Special Task Force (STF) on US Value Assessment Frameworks was agnostic about exactly how to implement the quality-adjusted life year (QALY) as a key element in an overall cost-effectiveness evaluation. But the STF recommended using the cost-per-QALY gained as a starting point...

Descripción completa

Detalles Bibliográficos
Autores principales: Zamora, Bernarda, Garrison, Louis P., Unuigbe, Aig, Towse, Adrian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923485/
https://www.ncbi.nlm.nih.gov/pubmed/33648523
http://dx.doi.org/10.1186/s12962-021-00266-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923485/
https://www.ncbi.nlm.nih.gov/pubmed/33648523
http://dx.doi.org/10.1186/s12962-021-00266-8

Ejemplares similares